Institut Bergonié [clinicaltrials_resource:ffe9530e82f9a20eda15d9ecc0027c99]
ETIENNE Gabriel, MD [clinicaltrials_resource:00d74f790130a68cdf716f670eaa1d15]Marc Debled, MD [clinicaltrials_resource:0b96d0674ba8dabc8cce2f3745e6d994]Pierre Soubeyran, MD, PhD [clinicaltrials_resource:0cd71cdb05701f7a79e5cdb242beacc6]Nadine Houede [clinicaltrials_resource:128aa45c7a725f3c68a81affd06e2a74]Jean PALUSSIERE, MD [clinicaltrials_resource:12f405eb3b5beed5e275368e55bf69ae]COLOMBANI Sylvie, MD [clinicaltrials_resource:1439a3acaf1f4c4b07c5d4ec43eb9a5c]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Marianne FONCK, MD [clinicaltrials_resource:17f9a5d2d855dc84d1dfb25716ce4bcf]Jean-Pierre GEKIERE, MD [clinicaltrials_resource:181f7e4e83d9cf3e8ea731c2b0edbf79]Guilhem Roubaud, MD [clinicaltrials_resource:18d2173089bfb79032c3e29d66356cbd]Pierre Soubeyran, MD, PhD [clinicaltrials_resource:1a9efb19658a0394098e4716a87ade18]Antoine ITALIANO, MD, PhD [clinicaltrials_resource:1adc4c34711353210142d6f0ec5172fd]Louis Mauriac, MD [clinicaltrials_resource:1ec9d41f3cd7c3d148441e4e9b746369]Maud TOULMONDE, Doctor [clinicaltrials_resource:22e6715c537e67005ea4f3fe70e86718]EVRARD Serge, PU-PH [clinicaltrials_resource:22fa00379bae81774525dd4862d29f75]Antoine ITALIANO, MD, PhD [clinicaltrials_resource:261048d68d4b75dc498cf411fd9824e3]Antoine Italiano, MD [clinicaltrials_resource:27b000267a19a9433e11c6ec550383e8]ITALIANO Antoine, MD [clinicaltrials_resource:27f45afe2f844e755eb560e6147e5b52]ROBERT Jacques, PU-PH [clinicaltrials_resource:2d7a848c91c8627505c1f0ebbc619d84]Serge EVRARD, Pr [clinicaltrials_resource:318da3c65fe8c86af4ce7a797c7a5b7f]Fabienne VALENTIN, MD [clinicaltrials_resource:37ee43d8593bf6c8e8ca2631a94d8f89]COLOMBANI Sylvie, MD [clinicaltrials_resource:380faaf11f279c6b62085cb9976d6be9]Serge Evrard, Prof. [clinicaltrials_resource:3890617d05c3b9ef36685c8ece763070]Maud TOULMONDE, Doctor [clinicaltrials_resource:3d7540307772e4164a9973fd7f206fa0]Marianne Fonck, MD [clinicaltrials_resource:3de147366ff60043d730b3f48fc21e6f]Francoise Bonichon, MD [clinicaltrials_resource:3fa8422a2ed6b1d944dca71c4f30aea3]CAZEAU Anne Laure, MD [clinicaltrials_resource:41f25561fde77ce65b8b1c3709db25ce]Serge Evrard [clinicaltrials_resource:4649e0b1bf40482ee33b5279896d0684]ETIENNE Gabriel, MD [clinicaltrials_resource:46fd0e02365ea2705880a0fe4b484d1a]Maud TOULMONDE, Doctor [clinicaltrials_resource:471b88f91335f6652d8c795974aedf3b]Antoine ITALIANO, MD, PhD [clinicaltrials_resource:47f0f4926767de71ba7fe972c36bb95e]EVRARD Serge, PU-PH [clinicaltrials_resource:4897d62db2f3dc1025b1b96dd4ec4a24]Pierre SOUBEYRAN, MD, PhD [clinicaltrials_resource:4df1ab174326452612f444b8b05cdec7]EVRARD Serge, PU-PH [clinicaltrials_resource:5bf764ea1678ce27c0c4fa5325f9721a]Pierre Richaud, MD [clinicaltrials_resource:5c97c9e7f409e56e0aab77a80073411e]PALUSSIERE Jean, MD [clinicaltrials_resource:5e039d2743b1ef0b07cd34448045a9ae]Nguyen Binh Bui, MD [clinicaltrials_resource:647f5234048b49dc97cf181aa3fa7829]Yves Becouarn, MD [clinicaltrials_resource:65a75f32356e5f7db783b36aab59f6e5]ETIENNE Gabriel, MD [clinicaltrials_resource:673c05dec94dcdc0844a9ffbb18ff0d8]Louis Mauriac, MD [clinicaltrials_resource:6ccf4e10f264e6d728508c0748ffbf81]
affiliation [clinicaltrials_vocabulary:affiliation]
Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response [clinicaltrials:NCT00210119]Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer [clinicaltrials:NCT00210171]Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer [clinicaltrials:NCT00210184]Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment [clinicaltrials:NCT00210249]clinicaltrials:NCT01827943clinicaltrials:NCT01841060Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial [clinicaltrials:NCT01876043]clinicaltrials:NCT02406781clinicaltrials:NCT02517918
collaborator [clinicaltrials_vocabulary:collaborator]
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. [clinicaltrials:NCT00210106]Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response [clinicaltrials:NCT00210119]Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery [clinicaltrials:NCT00210132]Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer. [clinicaltrials:NCT00210145]Intraoperative Nitrous Oxide and Postoperative Pain for Patients With Current Opioid Treatment [clinicaltrials:NCT00210158]Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer [clinicaltrials:NCT00210171]Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer [clinicaltrials:NCT00210184]Hypercoagulability After Breast Cancer Surgery [clinicaltrials:NCT00210197]Administration of Ketamine to Prevent the Post-operative Pain [clinicaltrials:NCT00210210]Radiofrequency of Breast Cancers in Non Surgical Patients [clinicaltrials:NCT00210223]Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer [clinicaltrials:NCT00210236]Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment [clinicaltrials:NCT00210249]PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases [clinicaltrials:NCT00382252]Effect of Advertisements on Treatment Compliance in Women With Breast Cancer [clinicaltrials:NCT00462410]MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer [clinicaltrials:NCT00462696]Psychological and Social Factors That May Increase the Risk of Developing Chronic Pain After Surgery in Women With Breast Cancer [clinicaltrials:NCT00466830]Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery [clinicaltrials:NCT00467142]Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer [clinicaltrials:NCT00712712]Combination Chemotherapy and Cetuximab in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer [clinicaltrials:NCT00766142]Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer [clinicaltrials:NCT00871858]Rituximab, Cyclophosphamide, Vincristine Sulfate, and Prednisone With or Without Liposome-Encapsulated Doxorubicin Citrate in Treating Older Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin Lymphoma [clinicaltrials:NCT00911183]Questionnaire in Screening Older Patients With Cancer [clinicaltrials:NCT00963911]Efavirenz in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00964002]Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer [clinicaltrials:NCT00964171]Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines [clinicaltrials:NCT01754597]clinicaltrials:NCT01827930clinicaltrials:NCT01827943Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms [clinicaltrials:NCT01827956]Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy [clinicaltrials:NCT01827969]Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma [clinicaltrials:NCT01841047]clinicaltrials:NCT01841060Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast [clinicaltrials:NCT01841749]Erectile Rating During the Treatment of Rectal Cancers Localized [clinicaltrials:NCT01843218]Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial [clinicaltrials:NCT01876043]clinicaltrials:NCT01876082Efficacy of Delayed Coloanal Anastomosis for Medium and Lower Rectum Cancer Treatment. Phase 2 Clinical Trial (CASCADOR) [clinicaltrials:NCT01876901]Phase I Dose Escalation Trial of Efavirenz for Patients With Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure. [clinicaltrials:NCT01878890]clinicaltrials:NCT01880541clinicaltrials:NCT01880554PET Enhanced CT Scan Performance in Cancer [clinicaltrials:NCT01881620]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. [clinicaltrials:NCT00210106]Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response [clinicaltrials:NCT00210119]Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery [clinicaltrials:NCT00210132]Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer. [clinicaltrials:NCT00210145]Intraoperative Nitrous Oxide and Postoperative Pain for Patients With Current Opioid Treatment [clinicaltrials:NCT00210158]Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer [clinicaltrials:NCT00210171]Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer [clinicaltrials:NCT00210184]Hypercoagulability After Breast Cancer Surgery [clinicaltrials:NCT00210197]Administration of Ketamine to Prevent the Post-operative Pain [clinicaltrials:NCT00210210]Radiofrequency of Breast Cancers in Non Surgical Patients [clinicaltrials:NCT00210223]Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer [clinicaltrials:NCT00210236]Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment [clinicaltrials:NCT00210249]Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines [clinicaltrials:NCT01754597]clinicaltrials:NCT01827930clinicaltrials:NCT01827943Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms [clinicaltrials:NCT01827956]Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy [clinicaltrials:NCT01827969]Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma [clinicaltrials:NCT01841047]clinicaltrials:NCT01841060Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast [clinicaltrials:NCT01841749]Erectile Rating During the Treatment of Rectal Cancers Localized [clinicaltrials:NCT01843218]Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial [clinicaltrials:NCT01876043]clinicaltrials:NCT01876082Efficacy of Delayed Coloanal Anastomosis for Medium and Lower Rectum Cancer Treatment. Phase 2 Clinical Trial (CASCADOR) [clinicaltrials:NCT01876901]Phase I Dose Escalation Trial of Efavirenz for Patients With Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure. [clinicaltrials:NCT01878890]clinicaltrials:NCT01880541clinicaltrials:NCT01880554PET Enhanced CT Scan Performance in Cancer [clinicaltrials:NCT01881620]Feasability Study on the Contribution of Guided Puncture With Echoendoscopy [clinicaltrials:NCT01892501]Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib [clinicaltrials:NCT01907607]clinicaltrials:NCT02406781clinicaltrials:NCT02517918
source [clinicaltrials_vocabulary:source]
Institut Bergonié [clinicaltrials_resource:ffe9530e82f9a20eda15d9ecc0027c99]
Bio2RDF identifier
ffe9530e82f9a20eda15d9ecc0027c99
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ffe9530e82f9a20eda15d9ecc0027c99
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:ffe9530e82f9a20eda15d9ecc0027c99
title
Institut Bergonié
@en
type
label
Institut Bergonié [clinicaltrials_resource:ffe9530e82f9a20eda15d9ecc0027c99]
@en